rss
Br J Ophthalmol doi:10.1136/bjophthalmol-2011-301332
  • Clinical science

The effect on quality of life of long-term botulinum toxin A injections to maintain ocular alignment in adult patients with strabismus

  1. Gill Adams
  1. Strabismus and Paediatrics, Moorfields Eye Hospital, City Road, London, UK
  1. Correspondence to Joanne Hancox, Strabismus and Paediatrics, Moorfields Eye Hospital, City Road, London, EC1V 2PD, UK; johancox{at}doctors.org.uk
  1. Contributors JH: substantial contribution to conception and design, acquisition of data or analysis and interpretation of data; drafting the article or viewing it critically for important intellectual content; final approval of the article. SS: substantial contribution to conception and design, acquisition of data or analysis and interpretation of data. KM: substantial contribution to conception and design, acquisition of data or analysis and interpretation of data. GA: drafting the article or viewing it critically for important intellectual content; final approval of the article.

  • Accepted 29 January 2012
  • Published Online First 24 February 2012

Abstract

Background There is considerable evidence to show that strabismus patients report their quality of life (QoL) as lower than normal controls. While the majority of patients with strabismus are treated with surgery there are a number of cases where surgery is not possible and good long-term ocular alignment can be maintained with repeated injections of botulinum toxin.

Methods 65 patients who had undergone over 25 injections of botulinum toxin A for long-term control of their deviation were identified and asked to fill in and return the Adult Strabismus questionnaire (AS-20) to assess their QoL.

Results 46 questionnaires were available for analysis. The mean AS-20 score in our patients compared favourably with that reported for normal controls and was much higher than that reported for patients with strabismus.

Conclusion Long-term injections with botulinum toxin A is a good treatment for maintaining ocular alignment if squint surgery is not indicated and those patients receiving treatment score near the level of normal controls in QoL terms.

Footnotes

  • Funding This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

  • Competing interests None.

  • Ethics approval Approval provided by Moorfields Eye Hospital Audit Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

This article has not yet been cited by other articles.

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.